论文部分内容阅读
1病例介绍患者男,44岁。主因腹痛2个月,CT发现肝占位2 d入院。患者2个月前无明显诱因出现上腹部隐痛,2010年3月18日门诊查血甲胎蛋白(AFP)90 ng/mL,乙型肝炎(乙肝)标志物:乙肝表面抗原(+),乙肝核心抗体(+),余阴性;2010年3月20上腹部增强CT提示中肝大小约6.5 cm肝占位(图1),门诊以“原发性肝癌”收治入院。患者既往体健,有长期乙肝病史;口服恩替卡韦片(商品名:博路定)0.5 mg,1次/d;HBV-DNA<1×103copies/mL。入院查体及术前检查:心肺腹
1 case description Patient male, 44 years old. Main abdominal pain for 2 months, CT found liver d 2 d admission. The patient developed upper abdominal pain 2 months ago with no obvious predisposition, 90 ng / mL of AFP at the clinic on March 18, 2010, hepatitis B (HB) markers: hepatitis B surface antigen (+), hepatitis B Core antibody (+), negative; March 20, 2010 on the abdomen enhanced CT tips liver size of about 6.5 cm liver occupancy (Figure 1), outpatient to “primary liver cancer ” admitted admitted. Patients with previous health, have a long history of hepatitis B; oral entecavir tablets (brand name: Bordetin) 0.5 mg, 1 / d; HBV-DNA <1 × 103copies / mL. Admission examination and preoperative examination: cardiopulmonary abdomen